Hemostemix (CVE:HEM) Trading 33.3% Higher – Should You Buy?
Shares of Hemostemix Inc. (CVE:HEM – Get Free Report) shot up 33.3% during trading on Wednesday . The stock traded as high as C$0.14 and last traded at C$0.14. 485,625 shares were traded during trading, an increase of 33% from the average session volume of 366,110 shares. The stock had previously closed at C$0.11. Hemostemix […]
More Stories
Canaccord Genuity Group Reiterates “Buy” Rating for Celldex Therapeutics (NASDAQ:CLDX)
Celldex Therapeutics (NASDAQ:CLDX – Get Free Report)‘s stock had its “buy” rating restated by Canaccord Genuity Group in a research...
Citigroup Issues Positive Forecast for GFL Environmental (NYSE:GFL) Stock Price
GFL Environmental (NYSE:GFL – Get Free Report) had its price target boosted by stock analysts at Citigroup from $58.00 to...
Critical Contrast: UniTek Global Services (OTCMKTS:UNTKQ) and Array Digital Infrastructure (NYSE:AD)
UniTek Global Services (OTCMKTS:UNTKQ – Get Free Report) and Array Digital Infrastructure (NYSE:AD – Get Free Report) are both transportation...
Q3 EPS Estimate for Lakeland Industries Boosted by Analyst
Lakeland Industries, Inc. (NASDAQ:LAKE – Free Report) – Stock analysts at Roth Capital lifted their Q3 2026 EPS estimates for...
What is Zacks Research’s Estimate for COO FY2025 Earnings?
The Cooper Companies, Inc. (NASDAQ:COO – Free Report) – Equities researchers at Zacks Research boosted their FY2025 earnings estimates for...
Zacks Research Raises Earnings Estimates for Exxon Mobil
Exxon Mobil Corporation (NYSE:XOM – Free Report) – Research analysts at Zacks Research lifted their FY2025 earnings estimates for Exxon...